USD 0.0
(8.7%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 | - USD | 0.0% |
2023 | - USD | -100.0% |
2022 | 76.58 Thousand USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2024 FY | - USD | 0.0% |
2024 Q4 | - USD | 0.0% |
2024 Q3 | - USD | 0.0% |
2023 FY | - USD | -100.0% |
2023 Q4 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | -100.0% |
2022 Q4 | 76.58 Thousand USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 FY | 76.58 Thousand USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2020 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
China Medicine Corporation | - USD | NaN% |
Exlites Holdings International, Inc. | - USD | NaN% |
Itonis, Inc. | - USD | NaN% |
One Step Vending Corp. | - USD | NaN% |
MediPal Holdings Corporation | - USD | NaN% |
PD-Rx Pharmaceuticals, Inc. | - USD | NaN% |
Pharmagen, Inc. | 770.31 USD | 100.0% |
Suzuken Co., Ltd. | - USD | NaN% |